v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period Of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period Of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Aug. 03, 2019     9,925,000        
Beginning balance at Aug. 03, 2019 $ 151.0   $ 0.1 $ 1,102.5 $ (935.9)   $ (15.7)
Beginning balance (Accounting Standards Update 2014-09) at Aug. 03, 2019   $ (11.5)       $ (11.5)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 31.7       31.7    
Total other comprehensive income 0.2           0.2
Shares issued and equity grants made pursuant to stock-based compensation plans (in shares)     47,000        
Shares issued and equity grants made pursuant to stock-based compensation plans 1.6     1.6      
Ending balance (in shares) at Nov. 02, 2019     9,972,000        
Ending balance at Nov. 02, 2019 $ 173.0   $ 0.1 1,104.1 (915.7)   (15.5)
Beginning balance (in shares) at Aug. 01, 2020 10,087,000   10,087,000        
Beginning balance at Aug. 01, 2020 $ (994.2)   $ 0.1 1,106.9 (2,089.2)   (12.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 76.3            
Total other comprehensive income 0.3           0.3
Shares issued and equity grants made pursuant to stock-based compensation plans (in shares)     3,000        
Shares issued and equity grants made pursuant to stock-based compensation plans $ 0.4     0.4      
Ending balance (in shares) at Oct. 31, 2020 10,090,000   10,090,000        
Ending balance at Oct. 31, 2020 $ (917.2)   $ 0.1 $ 1,107.3 $ (2,012.9)   $ (11.7)